AI-generated analysis. Always verify with the original filing.
BullFrog AI Holdings entered into a one-year feasibility agreement with a top 5 global pharmaceutical company to apply its bfLEAP platform to identify drug targets for major depressive disorder, with potential milestone payments and exclusive target access.
Event Type
Disclosure
Mandatory
Variant
8-K
. Entry Into a Material Definitive Agreement.** On March 27, 2026, BullFrog AI Holdings, Inc. (the “Company”) entered into a Feasibility Agreement (the “Agreeme
. Other Matters.** ** ** On March 30, 2026, the Company issued a press release announcing the entry into the Agreement. A copy of the press release is attached
. Financial Statements and Exhibits.** (d) Exhibits. The following exhibits are being furnished herein: | Exhibit No. | | Description | |---|---|---| | 10.1*# |
Material Agreement